Patent ID: 7357945
Filing Date: 2008-04-15
Classification: A61K

Abstract:
1. A tablet comprising of the following active ingredient and excipients, in weight to weight percentages: a) about 10% to about 12.5% of paroxetine hydrochloride as an active ingredient; b) about 70% to about 90% of dibasic calcium phosphate anhydrous; c) about 1.5% to about 5% of sodium starch glycolate; d) about 0.5% to about 3% of magnesium stearate; and e) about 2.5% to about 7.5% of povidone, wherein the tablet is prepared by wet granulating paroxetine hydrochloride in the presence of povidone, sodium starch glycolate and dibasic calcium phosphate anhydrous to obtain a granulate, and converting the granulate to a tablet.